Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Enveric Biosciences, Inc. Common Stock (ENVB)
Pharmaceutical Preparations
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).
4851 TAMIAMI TRAIL N, SUITE 200
NAPLES, FL
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/24/1995
Market Cap
4,559,863
Shares Outstanding
2,740,000
Weighted SO
2,739,315
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
0.4780
Last Div
0.0000
Range
0.41-2.92
Chg
0.0282
Avg Vol
1139259
Mkt Cap
4559863
Exch
NASDAQ
Country
US
Phone
239 302 1707
DCF Diff
-0.5672
DCF
1.0597
Div Yield
0.0000
P/S
7.0467
EV Multiple
-0.1144
P/FV
0.7175
Div Yield %
0.0000
P/E
-0.3661
PEG
-0.0098
Payout
0.0000
Current Ratio
7.3709
Quick Ratio
7.3709
Cash Ratio
5.4275
DSO
168.8328
DIO
0.0000
Op Cycle
168.8328
DPO
478.6383
CCC
-309.8056
Gross Margin
0.4580
Op Margin
-15.7752
Pretax Margin
-16.3251
Net Margin
-16.3724
Eff Tax Rate
-0.0017
ROA
-1.7507
ROE
-2.3416
ROCE
-1.8882
NI/EBT
1.0029
EBT/EBIT
1.0349
EBIT/Rev
-15.7752
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
-2965.7191
CF/Debt
0.0000
Equity Multi
1.1194
Rec Turnover
2.1619
Pay Turnover
0.7626
Inv Turnover
0.0000
FA Turnover
1.5973
Asset Turnover
0.1069
OCF/Share
-1.3151
FCF/Share
-1.3151
Cash/Share
0.4616
OCF/Sales
-15.4213
FCF/OCF
1.0000
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
-999999.9999
Div&CapEx Cov
-999999.9999
P/BV
0.7175
P/B
0.7175
P/S
7.0467
P/E
-0.3661
P/FCF
-0.4569
P/OCF
-0.3887
P/CF
-0.3887
PEG
-0.0098
P/S
7.0467
EV Multiple
-0.1144
P/FV
0.7175
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
210.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
1.00K Shares Bought (99.90 %)
0.00 Shares Sold (0.10 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
1970 | 1970 | 1970 | 1970 | 1970 | 1970 | 1970 |
---|
1970 | 1970 | 1970 | 1970 | 1970 | 1970 | 1970 |
---|
1970 | 1970 | 1970 | 1970 | 1970 | 1970 | 1970 |
---|
Generating AI Summary...
(This could take up to 5 minutes)